loader image
Sunday, October 5, 2025
72.6 F
McAllen
- Advertisement -

Low-cost, portable device could diagnose heart attacks in minutes

Translate to Spanish or other 102 languages!

Pinar Zorlutuna talks with one of her graduate students in her lab. Image by Matt Cashore/University of Notre Dame. Newswise image

Mega Doctor News

- Advertisement -

By University of Notre Dame

Newswise — Researchers from the University of Notre Dame and the University of Florida have developed a sensor that could diagnose a heart attack in less than 30 minutes, according to a study published in Lab on a Chip. 

Currently, it takes health care professionals hours to diagnose a heart attack. Initial results from an echocardiogram can quickly show indications of heart disease, but to confirm a patient is having a heart attack, a blood sample and analysis is required. Those results can take up to eight hours.

- Advertisement -

“The current methods used to diagnose a heart attack are not only time intensive, but they also have to be applied within a certain window of time to get accurate results,” said Pinar Zorlutuna, the Sheehan Family Collegiate Professor of Engineering at Notre Dame and lead author of the paper. “Because our sensor targets a combination of miRNA, it can quickly diagnose more than just heart attacks without the timeline limitation.”

By targeting three distinct types of microRNA or miRNA, the newly developed sensor can distinguish between an acute heart attack and a reperfusion — the restoration of blood flow, or reperfusion injury, and requires less blood than traditional diagnostic methods to do so. The ability to differentiate between someone with inadequate blood supply to an organ and someone with a reperfusion injury is an unmet, clinical need that this sensor addresses.

“The technology developed for this sensor showcases the advantage of using miRNA compared to protein-based biomarkers, the traditional diagnostic target,” said Hsueh-Chia Chang, the Bayer Professor of Chemical and Biomolecular Engineering at Notre Dame and co-author of the paper. “Additionally, the portability and cost efficiency of this device demonstrates the potential for it to improve how heart attacks and related issues are diagnosed in clinical settings and in developing countries.”

A patent application has been filed for the sensor and the researchers are working with Notre Dame’s IDEA Center to potentially establish a startup company that would manufacture the device.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

DHR Health Breast Cancer Symposium, Oct. 11th 

To support providers in the community, the DHR Health Continuing Medical Education Department will host the Breast Cancer Symposium on Saturday, October 11, at the Edinburg Conference Center at Renaissance, located at 118 Paseo del Prado.

STHS Children’s to Host Monster Jam Patient Meet & Greet, Oct. 9th

On Thursday, October 9, 2025, from 2:00 – 4:00 p.m., the pediatric patients at South Texas Health System Children’s will have the opportunity to experience monster truck magic without leaving the hospital grounds.

Why Lobular Breast Cancer Can be Difficult to Detect

Reports show that one in eight women will be diagnosed with breast cancer in their lifetime. 

DHR Health Introduces Advanced PSMA-PET Imaging with Illuccix® for Prostate Cancer Care

To support early and accurate detection, DHR Health now offers Illuccix (kit for the preparation of gallium Ga 68 gozetotide injection), a prostate-specific membrane antigen (PSMA) targeted positron emission tomography (PET) imaging tracer for the detection of prostate cancer.
- Advertisement -
×